US markets open Monday's session higher as Wall Street sentiment was reinforced by the easing of US-China tariff tensions. Stocks are also reacting to a series of corporate news. The Nasdaq is up 3.51% 30 minutes after Wall Street opens, while the S&P 500 is up 2.66%.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appCurrent volatility on Wall Street. Source: xStation
Automakers and retailers are leading in pre-market gains on the back of the US-China trade deal. Pharmaceuticals are down 1.8% on Donald Trump's promise to cut US drug prices. Breakdown of yields by sector. Source: Bloomberg Financial LP
US100
The Nasdaq-100 index, represented by the US100 contract, is trading nearly 4% higher today than it closed on Friday. The index continues to maintain a dynamic upward trend, illustrated by exponential moving averages (50-, 100- and 200-day EMAs, respectively). The US100 has already recovered almost 78% of the declines that have occurred since the beginning of the second half of February 2025.
Source: xStation 5
News
Pharmaceutical stocks fell today after President Donald Trump said he plans to order a reduction in the cost of prescription drugs in the US, raising concerns that their profits will suffer, but these moves have already been largely negated by favorable sentiment in the broader market. Eli Lilly (LLY.US) shares lost as much as 3% (they are currently losing “only” 0.7%); Pfizer (PFE.US) lost 2%, now gaining 2.7%.
Source: xStation
Falling gold prices amid lower economic concerns amid high tariffs are dragging down precious metals-focused miners. Barrick Mining Corp. (GOLD.US) is down 5%.
Shopify (SHOP.US) shares are up 10% after Nasdaq announced Friday that the Canadian e-commerce platform will replace MongoDB in the Nasdaq-100 index ahead of the May 19 market open.
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
